BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38625039)

  • 1. Prevalence of geriatric impairments and frailty categorization among real-world patients with multiple myeloma: a prospective cohort study (MFRAIL).
    Haider I; Leong DP; Louzada M; McCurdy A; Pond GR; Cameron R; Aljama M; Visram A; Wildes TM; Mian H
    Leuk Lymphoma; 2024 Apr; ():1-8. PubMed ID: 38625039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of IMWG frailty score with health-related quality of life profile of patients with relapsed refractory multiple myeloma in Italy and the UK: a GIMEMA, multicentre, cross-sectional study.
    Efficace F; Gaidano G; Petrucci MT; Niscola P; Cottone F; Codeluppi K; Antonioli E; Tafuri A; Larocca A; Potenza L; Fozza C; Pastore D; Rigolin GM; Offidani M; Romano A; Kyriakou C; Cascavilla N; Gozzetti A; Derudas D; Vignetti M; Cavo M
    Lancet Healthy Longev; 2022 Sep; 3(9):e628-e635. PubMed ID: 36102777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-reported frailty phenotype (PRFP) vs. International Myeloma Working Group frailty index (IMWG FI) proxy: A comparison between two approaches to measuring frailty.
    Murugappan MN; King-Kallimanis BL; Bhatnagar V; Kanapuru B; Farley JF; Seifert RD; Stenehjem DD; Chen TY; Horodniceanu EG; Kluetz PG
    J Geriatr Oncol; 2024 Mar; 15(2):101681. PubMed ID: 38104480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the frailty characteristics and clinical outcomes according to the new frailty-based outcome prediction model (Myeloma Risk Profile-MRP) in a UK real-world cohort of elderly newly diagnosed Myeloma patients.
    Djebbari F; Rampotas A; Panitsas F; Lim WY; Lees C; Tsagkaraki I; Gomes AR; Prideaux S; Chen L; Prodger C; Khera A; Gray N; Ellis L; Sangha G; Eyre TA; Moore S; Kothari J; Ramasamy K
    PLoS One; 2022; 17(1):e0262388. PubMed ID: 35015781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive geriatric assessment in newly diagnosed older myeloma patients: a multicentre, prospective, non-interventional study.
    Yao Y; Sui WW; Liao AJ; Wang W; Chen LJ; Chu XX; Bao L; Cen XN; Fu R; Liu H; Sun CY; Jin FY; Yan H; Wang LQ; Yuan CL; Gao GX; Gao D; Zhang JQ; He JX; Hu JD; Ma LM; Zhang L; Zhou DB; Zou DH; Li J
    Age Ageing; 2022 Jan; 51(1):. PubMed ID: 34673897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of three different approaches to defining frailty in older patients with multiple myeloma.
    Isaacs A; Fiala M; Tuchman S; Wildes TM
    J Geriatr Oncol; 2020 Mar; 11(2):311-315. PubMed ID: 31326393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of the International Myeloma Working Group myeloma frailty score among patients 75 and older.
    Murillo A; Cronin AM; Laubach JP; Hshieh TT; Tanasijevic AM; Richardson PG; Driver JA; Abel GA
    J Geriatr Oncol; 2019 May; 10(3):486-489. PubMed ID: 30472368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review.
    Mian H; McCurdy A; Giri S; Grant S; Rochwerg B; Winks E; Rosko AE; Engelhardt M; Pawlyn C; Cook G; Jackson G; Bringhen S; Facon T; Larocca A; Zweegman S; Wildes TM
    Blood Cancer J; 2023 Jan; 13(1):6. PubMed ID: 36599867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frail Multiple Myeloma Patients Deserve More Than Just a Score.
    Miller HL; Sharpley FA
    Hematol Rep; 2023 Feb; 15(1):151-156. PubMed ID: 36975728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Geriatric assessment in multiple myeloma patients: validation of the International Myeloma Working Group (IMWG) score and comparison with other common comorbidity scores.
    Engelhardt M; Dold SM; Ihorst G; Zober A; Möller M; Reinhardt H; Hieke S; Schumacher M; Wäsch R
    Haematologica; 2016 Sep; 101(9):1110-9. PubMed ID: 27479825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elderly patients with multiple myeloma: towards a frailty approach?
    Zweegman S; Engelhardt M; Larocca A;
    Curr Opin Oncol; 2017 Sep; 29(5):315-321. PubMed ID: 28763310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a new clinical index to easily assess frailty of elderly patients with multiple myeloma in Asian population.
    Lee HS; Lee J; Jo JC; Jung SH; Lee JJ; Kim D; Lee S; Song K
    Sci Rep; 2021 Nov; 11(1):22907. PubMed ID: 34824362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electronic FRAIL score may predict treatment outcomes in older adults with myeloma.
    Chan H; Chong YH; Seow MY; Li J; Garg P; Kelly M; Neylon A; McDiarmid B; Tan S; Jackson S
    J Geriatr Oncol; 2021 May; 12(4):515-520. PubMed ID: 33046409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of frailty assessment in multiple myeloma: a position statement from the Myeloma Scientific Advisory Group to Myeloma Australia.
    Sim S; Kalff A; Tuch G; Mollee P; Ho PJ; Harrison S; Gibbs S; Prince HM; Spencer A; Joshua D; Lee C; Ling S; Murphy N; Szabo F; Szer J; Weber N; Ward C; Talaulikar D; Zannettino A; Quach H
    Intern Med J; 2023 May; 53(5):819-824. PubMed ID: 36880355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Frailty on Outcomes after Chimeric Antigen Receptor T Cell Therapy for Patients with Relapsed/Refractory Multiple Myeloma.
    Davis JA; Dima D; Ahmed N; DeJarnette S; McGuirk J; Jia X; Raza S; Khouri J; Valent J; Anwer F; Abdallah AO; Hashmi H
    Transplant Cell Ther; 2024 Mar; 30(3):298-305. PubMed ID: 38142943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Frailty Scores in Newly Diagnosed Patients with Multiple Myeloma: A Review.
    Mian H; Brouwers M; Kouroukis CT; Wildes TM
    J Frailty Aging; 2019; 8(4):215-221. PubMed ID: 31637409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. More intensive therapy as more effective treatment for frail patients with multiple myeloma [corrected].
    DuMontier C; La J; Bihn J; Corrigan J; Yildirim C; Dharne M; Hassan H; Yellapragada S; Abel GA; Gaziano JM; Do NV; Brophy M; Kim DH; Munshi NC; Fillmore NR; Driver JA
    Blood Adv; 2023 Oct; 7(20):6275-6284. PubMed ID: 37582048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is comprehensive geriatric testing guiding in the identification of multiple myeloma patients who are candidates for autologous stem cell transplantation? A prospective analysis.
    Demirel KD; Özkurt ZN; Doğrul RT; Kaynar LA; Yeğin ZA; Göker B; Yağci M
    Ann Hematol; 2022 Dec; 101(12):2691-2697. PubMed ID: 36195680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplant-ineligible newly diagnosed multiple myeloma: Current and future approaches to clinical care: A Young International Society of Geriatric Oncology Review Paper.
    Grant SJ; Mian HS; Giri S; Boutin M; Dottorini L; Neuendorff NR; Krok-Schoen JL; Nikita N; Rosko AE; Wildes TM; Zweegman S
    J Geriatr Oncol; 2021 May; 12(4):499-507. PubMed ID: 33342724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a Medicare Health Outcomes Survey Deficit-Accumulation Frailty Index and Its Application to Older Patients With Newly Diagnosed Multiple Myeloma.
    Mian HS; Wildes TM; Fiala MA
    JCO Clin Cancer Inform; 2018; 2():. PubMed ID: 30547157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.